Ensysce Biosciences Announces Positive Interim Data for Breakthrough Therapy PF614-MPAR

Go back to Ensysce Biosciences Announces Positive Interim Data for Breakthrough Therapy PF614-MPAR
(NASDAQ: ENSC) Delayed: 0.29 +0.01 (3.57%)
Previous Close $0.28    52 Week High
Open $0.26    52 Week Low
Day High $0.31    P/E N/A 
Day Low $0.24    EPS
Volume 19,719,244